×
About 7,613 results

ALLMedicine™ Contact Dermatitis Center

Research & Reviews  2,000 results

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
https://clinicaltrials.gov/ct2/show/NCT02973789

Jun 23rd, 2022 - PAST PRE-CLINICAL AND CLINICAL EXPERIENCE: The effect of the electric fields (TTFields, TTF) has demonstrated significant activity in in vitro and in vivo NSCLC pre-clinical models both as a single modality treatment and in combination with chemot...

Black-Spot Toxicodendron Dermatitis With Varied Presentation.
https://doi.org/10.1016/j.wem.2022.05.002
Wilderness & Environmental Medicine; Rabinovich EP, Barquin JN et. al.

Jun 20th, 2022 - This article describes the clinical presentation, differential diagnosis, and treatment of 2 unrelated cases with different presentations of black-spot Toxicodendron dermatitis. In the first case, a healthy 7-y-old male presented with a rash consi...

Dyshidrotic Eczema (Pompholyx)
http://emedicine.medscape.com/article/1122527-overview

Jun 20th, 2022 - Practice Essentials Dyshidrotic eczema, also termed pompholyx, is a type of eczema (dermatitis). This skin condition is characterized by intensely itchy blisters that develop on the edges of the fingers, toes, palms, and soles of the feet. Dyshidr...

Dyshidrotic Eczema (Pompholyx)
https://emedicine.medscape.com/article/1122527-overview

Jun 20th, 2022 - Practice Essentials Dyshidrotic eczema, also termed pompholyx, is a type of eczema (dermatitis). This skin condition is characterized by intensely itchy blisters that develop on the edges of the fingers, toes, palms, and soles of the feet. Dyshidr...

Dyshidrotic Eczema (Pompholyx)
https://emedicine.medscape.com/article/1122527-print

Jun 20th, 2022 - Practice Essentials Dyshidrotic eczema, also termed pompholyx, is a type of eczema (dermatitis). This skin condition is characterized by intensely itchy blisters that develop on the edges of the fingers, toes, palms, and soles of the feet. Dyshidr...

see more →

Guidelines  7 results

Typical Contact Dermatitis Screening Misses Many Allergens
https://www.medscape.com/viewarticle/962856
Medscape Frellick M.

Nov 12th, 2021 - Standard patch test screening, which tests for up to 70 allergens for patients with allergic contact dermatitis, is limited and may miss many allergens, a study published in JAMA Dermatology has found. Dr Erin M. Warshaw The cross-sectiona...

Diagnosis and Management of Vulvar Skin Disorders: ACOG Practice Bulletin Summary, Numb...
https://doi.org/10.1097/AOG.0000000000003945
Obstetrics and Gynecology;

Jun 27th, 2020 - Vulvar skin disorders include a variety of inflammatory conditions of the vulva that also may affect the extragenital area. Pruritus and pain are two of the most common presenting symptoms in vulvar clinics (). Vulvovaginal symptoms often are chro...

Diagnosis and Management of Vulvar Skin Disorders: ACOG Practice Bulletin, Number 224.
https://doi.org/10.1097/AOG.0000000000003944
Obstetrics and Gynecology;

Jun 27th, 2020 - Vulvar skin disorders include a variety of inflammatory conditions of the vulva that also may affect the extragenital area. Pruritus and pain are two of the most common presenting symptoms in vulvar clinics (). Vulvovaginal symptoms often are chro...

Position statement of the European Academy of Dermatology and Venereology Task Force on...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301033
Journal of the European Academy of Dermatology and Venere... Chernyshov PV, Tomas-Aragones L et. al.

Jun 5th, 2020 - The pandemic of COVID-19 is a global challenge for health care, and dermatologists are not standing apart from trying to meet this challenge. The European Academy of Dermatology and Venereology (EADV) has collected recommendations from its Task Fo...

EAACI position paper for practical patch testing in allergic contact dermatitis in chil...
https://doi.org/10.1111/pai.12463
Pediatric Allergy and Immunology : Official Publication O... de Waard-van der Spek FB, Darsow U et. al.

Aug 20th, 2015 - Allergic contact dermatitis (ACD) in children appears to be on the increase, and contact sensitization may already begin in infancy. The diagnosis of contact dermatitis requires a careful evaluation of a patient's clinical history, physical examin...

see more →

Drugs  453 results see all →

Clinicaltrials.gov  78 results

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
https://clinicaltrials.gov/ct2/show/NCT02973789

Jun 23rd, 2022 - PAST PRE-CLINICAL AND CLINICAL EXPERIENCE: The effect of the electric fields (TTFields, TTF) has demonstrated significant activity in in vitro and in vivo NSCLC pre-clinical models both as a single modality treatment and in combination with chemot...

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)
https://clinicaltrials.gov/ct2/show/NCT03377491

Jun 15th, 2022 - PAST PRE-CLINICAL AND CLINICAL EXPERIENCE: The effect of the electric fields (TTFields, TTF) has demonstrated significant activity in in vitro and in vivo pancreatic adenocarcinoma pre-clinical models both as a single modality treatment and in com...

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Advanced Non-small Cell Lung Cancer (NSCLC)
https://clinicaltrials.gov/ct2/show/NCT04892472

Jun 3rd, 2022 - TTFields have demonstrated significant activity in in-vitro and NSCLC pre-clinical models, both as a single modality treatment and in combination with chemotherapies and PD-1 inhibitors. With taxanes, TTFields have been demonstrated to act synergi...

An Explorative Study of Treatment of Contact Dermatitis Due to DiabetesDevices
https://clinicaltrials.gov/ct2/show/NCT04909983

Jun 1st, 2022 - A feasibility study of treatment with a occlusive medical device or patch in pediatric patients with type 1 diabetes suffering from irritative contact dermatitis due to diabetes devices.

Topical Dermaprazole for Radiation Dermatitis in Breast Cancer and Head and Neck Cancer Patients (TOPAZ)
https://clinicaltrials.gov/ct2/show/NCT05269160

May 5th, 2022 - For this study, patients will be stratified into one of the following two arms: 1) head and neck or 2) breast cancer. All study participants will begin using Dermaprazole for 1-2 weeks prior to receiving radiation. During the CT Simulation, study ...

see more →

News  494 results

Going Beyond Hydroquinone: Alternative Skin Lightening Agents
https://www.mdedge.com/dermatology/article/255255/pigmentation-disorders/going-beyond-hydroquinone-alternative-skin
Nicole C. Syder, BA, Nada Elbuluk, MD, MSc

Jun 7th, 2022 - Disorders of hyperpigmentation—melasma, postinflammatory hyperpigmentation, lichen planus pigmentosus, erythema dyschromicum perstans, and pigmented contact dermatitis, among others—are common and challenging to treat. Although they can affect ind.

Higher sensitivity to contact allergens in children with atopic dermatitis
https://www.mdedge.com/dermatology/article/254741/atopic-dermatitis/higher-sensitivity-contact-allergens-children-atopic

May 18th, 2022 - Key clinical point: Children with atopic dermatitis (AD) may have a higher sensitivity to contact allergens, such as fragrances and metals, than children without AD. Major finding: Overall, 36.

Dupilumab for Allergic Contact Dermatitis: An Overview of Its Use and Impact on Patch Testing
https://www.mdedge.com/dermatology/article/254687/contact-dermatitis/dupilumab-allergic-contact-dermatitis-overview-its-use
Hadley Johnson, BS, Brandon L. Adler, MD et. al.

May 17th, 2022 - Dupilumab is a humanized monoclonal antibody approved by the US Food and Drug Administration (FDA) for the treatment of moderate to severe atopic dermatitis. Through inhibition of the IL-4R α subunit, it prevents activation of the IL-4/IL-13 signa.

Allergic Dermatitis: What's the Optimum Duration for the Repeated Open Application Test (ROAT)?
https://www.medscape.com/viewarticle/973340

May 3rd, 2022 - When performing the repeated open application test (ROAT) for allergic dermatitis, a minimum 10-day application period is needed to be confident that a positive result will be detected, according to a new prospective study out of France. Researche...

The Science of Clean Skin Care and the Clean Beauty Movement
https://www.medscape.com/viewarticle/972975

Apr 29th, 2022 - As the clean beauty movement is gaining momentum, it has become challenging to differentiate between science and marketing hype. I see numerous social media posts, blogs, and magazine articles about toxic skin care ingredients, while more patients...

see more →

Patient Education  13 results see all →